Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 1, p. s512, 2025. DOI: 10.25251/skin.9.supp.512. Disponível em: https://skin.dermsquared.com/skin/article/view/3151. Acesso em: 18 apr. 2025.